[Hemostasis and pathogenetic therapy of unstable angina pectoris].
Peculiar features of clinical course and outcomes of unstable angina are outlined with respect to severity of disturbances of interrelated coagulation, fibrinolytic and kallikrein systems, variants of DIC-syndrome run and antithrombotic treatment. The authors also give the description of laboratory methods of control over adequacy of anticoagulant and thrombolytic therapy and the analysis of effectiveness of transcutaneous transluminal coronary angioplasty and its action on factor Hageman system. The highest response was obtained in the group of patients on combined prolonged heparic treatment.
Krashutskii
V V
VV
Central Military Clinic Hospital of AA Vishnevskii, Moscow.
Rakov
A L
AL
Pyr'ev
A N
AN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000789:Angina, Unstable / Q000097:blood* / Q000175:diagnosis / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D004359:Drug Therapy, Combination; D005174:Factor XII / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D006487:Hemostasis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015912:Thrombolytic Therapy / Q000379:methods*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D005174:Factor XII